{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T18:43:04Z","timestamp":1783536184425,"version":"3.55.0"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Innovationsfonds of the German Federal Joint Committee","award":["01VSF17053"],"award-info":[{"award-number":["01VSF17053"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Frailty is associated with negative health outcomes in geriatric patients. A large proportion of frail patients is affected by polypharmacy, which in turn may be a possible cause of frailty. The cluster randomised controlled COFRAIL trial investigated the effects of family conferences to improve the care of frail patients. Deprescribing and communication about prioritising health goals between patients, relatives and general practitioners were key components of the intervention. An accompanying process evaluation was conducted to investigate whether the study intervention was implemented as intended and to describe the experiences of the target groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The process evaluation took place between February 2019 and October 2021 and followed international guidelines. Process parameters were collected using study documentation, standardised questionnaires and guided telephone interviews with a convenience sample of patients, relatives and general practitioners. Quantitative data were analysed descriptively, qualitative data through content analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Almost all general practitioners in the intervention group completed both mandatory trainings. Overall, 68% of the patients took part in all three planned family conferences, 85% in at least two. Patients, relatives and general practitioners reported positive experiences with the family conferences. Patients and relatives felt involved in the decision-making process and had predominantly no concerns when medication was discontinued. Only a few general practitioners considered the implementation of family conferences in regular care to be impractical. A supportive pharmacological hotline was not utilised frequently by the general practitioners. Due to the SARS-CoV-2 pandemic, some study procedures were adapted but did not have any negative impact.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>While the COFRAIL study did not achieve its primary goals, we identified no major barriers in the implementation of the intervention programme. Overall, the target groups experienced the approach of family conferences positively. However, the process evaluation provides valuable lessons for designing and implementing similar interventions in the future.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0350664","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T17:26:54Z","timestamp":1783531614000},"page":"e0350664","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Complex intervention programme to improve patient safety and facilitate deprescribing in frail older patients living at home (COFRAIL): A process evaluation of a cluster randomised controlled trial"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6985-1530","authenticated-orcid":true,"given":"Jens","family":"Abraham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Fleischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim","family":"Mortsiefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Drewelow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Ritzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitt","family":"Wiese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3469-092X","authenticated-orcid":true,"given":"Charalabos Markos","family":"Dintsios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8594-0537","authenticated-orcid":true,"given":"Veronika","family":"Bencheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Th\u00fcrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Wilm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the COFRAIL study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"issue":"7","key":"pone.0350664.ref001","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/bcp.13590","article-title":"The relationship between frailty and polypharmacy in older people: A systematic review","volume":"84","author":"M Guti\u00e9rrez-Valencia","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"pone.0350664.ref002","first-page":"433","article-title":"Frailty syndrome: an overview","volume":"9","author":"X Chen","year":"2014","journal-title":"Clin Interv Aging"},{"issue":"3","key":"pone.0350664.ref003","doi-asserted-by":"crossref","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"LP Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"pone.0350664.ref004","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13690-015-0068-x","article-title":"Burden of frailty in the elderly population: perspectives for a public health challenge","volume":"73","author":"F Buckinx","year":"2015","journal-title":"Arch Public Health"},{"key":"pone.0350664.ref005","doi-asserted-by":"crossref","first-page":"101498","DOI":"10.1016\/j.arr.2021.101498","article-title":"Prevalence of multidimensional frailty and pre-frailty in older people in different settings: A systematic review and meta-analysis","volume":"72","author":"N Veronese","year":"2021","journal-title":"Ageing Res Rev"},{"issue":"1","key":"pone.0350664.ref006","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1089\/rej.2007.0569","article-title":"Development and validation of a multidimensional prognostic index for one-year mortality from comprehensive geriatric assessment in hospitalized older patients","volume":"11","author":"A Pilotto","year":"2008","journal-title":"Rejuvenation Res"},{"issue":"12","key":"pone.0350664.ref007","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1111\/jgs.13153","article-title":"Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review","volume":"62","author":"TR Fried","year":"2014","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"pone.0350664.ref008","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1080\/14740338.2018.1546841","article-title":"An update on the clinical consequences of polypharmacy in older adults: a narrative review","volume":"17","author":"JW Wastesson","year":"2018","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"pone.0350664.ref009","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jamda.2019.10.022","article-title":"Adverse Outcomes of Polypharmacy in Older People: Systematic Review of Reviews","volume":"21","author":"LE Davies","year":"2020","journal-title":"J Am Med Dir Assoc"},{"issue":"10","key":"pone.0350664.ref010","doi-asserted-by":"crossref","DOI":"10.1093\/gerona\/55.10.M554","article-title":"Polypharmacy and hospitalization among older home care patients","volume":"55","author":"JH Flaherty","year":"2000","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"pone.0350664.ref011","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/ageing\/afz127","article-title":"Investigation of a possible association of potentially inappropriate medication for older adults and frailty in a prospective cohort study from Germany","volume":"49","author":"DC Muhlack","year":"2019","journal-title":"Age Ageing"},{"issue":"1","key":"pone.0350664.ref012","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","article-title":"What is polypharmacy? A systematic review of definitions","volume":"17","author":"N Masnoon","year":"2017","journal-title":"BMC Geriatr"},{"issue":"3","key":"pone.0350664.ref013","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s41999-021-00479-3","article-title":"Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences","volume":"12","author":"F Pazan","year":"2021","journal-title":"Eur Geriatr Med"},{"key":"pone.0350664.ref014","doi-asserted-by":"crossref","first-page":"2042098620933741","DOI":"10.1177\/2042098620933741","article-title":"An overview of prevalence, determinants and health outcomes of polypharmacy","volume":"11","author":"M Khezrian","year":"2020","journal-title":"Ther Adv Drug Saf"},{"issue":"3","key":"pone.0350664.ref015","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.4723","article-title":"Family Conferences to Facilitate Deprescribing in Older Outpatients With Frailty and With Polypharmacy: The COFRAIL Cluster Randomized Trial","volume":"6","author":"A Mortsiefer","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"1","key":"pone.0350664.ref016","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s13063-020-4182-x","article-title":"Family conferences and shared prioritisation to improve patient safety in the frail elderly (COFRAIL): study protocol of a cluster randomised intervention trial in primary care","volume":"21","author":"A Mortsiefer","year":"2020","journal-title":"Trials"},{"issue":"5","key":"pone.0350664.ref017","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","article-title":"Reducing inappropriate polypharmacy: the process of deprescribing","volume":"175","author":"IA Scott","year":"2015","journal-title":"JAMA Intern Med"},{"key":"pone.0350664.ref018","article-title":"Too much medicine in older people? Deprescribing through shared decision making","volume":"353","author":"J Jansen","year":"2016","journal-title":"BMJ"},{"issue":"12","key":"pone.0350664.ref019","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1111\/bcp.13742","article-title":"Identification of behaviour change techniques in deprescribing interventions: a systematic review and meta-analysis","volume":"84","author":"CR Hansen","year":"2018","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"pone.0350664.ref020","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.pec.2006.10.004","article-title":"Factors associated with medication hassles experienced by family caregivers of older adults","volume":"66","author":"SS Travis","year":"2007","journal-title":"Patient Educ Couns"},{"issue":"1","key":"pone.0350664.ref021","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12877-019-1274-0","article-title":"Needs and skills of informal caregivers to care for a dependent person: a cross-sectional study","volume":"19","author":"MDACR Dixe","year":"2019","journal-title":"BMC Geriatr"},{"issue":"5","key":"pone.0350664.ref022","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1111\/hex.13318","article-title":"Tools to evaluate medication management for caregivers of people living with dementia: A systematic review","volume":"24","author":"M Gench","year":"2021","journal-title":"Health Expect"},{"issue":"6","key":"pone.0350664.ref023","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/jep.13551","article-title":"Caregivers\u2019 experiences of medication management advice for people living with dementia at discharge","volume":"27","author":"MJ Sawan","year":"2021","journal-title":"J Eval Clin Pract"},{"key":"pone.0350664.ref024","doi-asserted-by":"crossref","DOI":"10.5334\/ijic.1543","article-title":"Patient participation in discharge planning conference","volume":"14","author":"A B\u00e5ngsbo","year":"2014","journal-title":"Int J Integr Care"},{"issue":"3","key":"pone.0350664.ref025","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/0269216316658833","article-title":"What is the evidence for conducting palliative care family meetings? A systematic review","volume":"31","author":"PJ Cahill","year":"2017","journal-title":"Palliat Med"},{"key":"pone.0350664.ref026","doi-asserted-by":"crossref","first-page":"109499","DOI":"10.1016\/j.pec.2026.109499","article-title":"Family meetings in palliative care: A systematic review","volume":"146","author":"T Guan","year":"2026","journal-title":"Patient Educ Couns"},{"issue":"11","key":"pone.0350664.ref027","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1007\/s00134-024-07579-1","article-title":"European Society of Intensive Care Medicine guidelines on end of life and palliative care in the intensive care unit","volume":"50","author":"J Kesecioglu","year":"2024","journal-title":"Intensive Care Med"},{"issue":"6","key":"pone.0350664.ref028","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamda.2023.03.003","article-title":"Systematic Review of Psychotropic Adverse Drug Event Monitoring Tools for Use in Long-Term Care Facilities","volume":"24","author":"BE McInerney","year":"2023","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"pone.0350664.ref029","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12904-025-01978-x","article-title":"Caregiver perceptions of the impact and effect of family conferences for patients with complex and high-level palliative care needs: a cross-sectional survey study","volume":"25","author":"A Nascimento","year":"2026","journal-title":"BMC Palliat Care"},{"issue":"4","key":"pone.0350664.ref030","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/jocn.17007","article-title":"Conducting family meetings on families with dementia: An integrative review","volume":"33","author":"H Zhang","year":"2024","journal-title":"J Clin Nurs"},{"key":"pone.0350664.ref031","doi-asserted-by":"crossref","first-page":"20420986221122684","DOI":"10.1177\/20420986221122684","article-title":"Development of a deprescribing manual for frail older people for use in the COFRAIL study and in primary care","volume":"13","author":"N-K Mann","year":"2022","journal-title":"Ther Adv Drug Saf"},{"key":"pone.0350664.ref032","doi-asserted-by":"crossref","first-page":"100032","DOI":"10.1016\/j.pecinn.2022.100032","article-title":"Development of a shared decision-making intervention to improve drug safety and to reduce polypharmacy in frail elderly patients living at home","volume":"1","author":"E Drewelow","year":"2022","journal-title":"PEC Innov"},{"key":"pone.0350664.ref033","article-title":"A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance","volume":"374","author":"K Skivington","year":"2021","journal-title":"BMJ"},{"key":"pone.0350664.ref034","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1745-6215-14-15","article-title":"Process evaluations for cluster-randomised trials of complex interventions: a proposed framework for design and reporting","volume":"14","author":"A Grant","year":"2013","journal-title":"Trials"},{"key":"pone.0350664.ref035","author":"P Mayring","year":"2014"},{"key":"pone.0350664.ref036","volume-title":"Practice book transcription. Control systems, software and practical guidelines for qualitative researchers","author":"T Dresing","year":"2013","edition":"4"},{"issue":"12","key":"pone.0350664.ref037","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006544","article-title":"Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis","volume":"4","author":"K Anderson","year":"2014","journal-title":"BMJ Open"},{"issue":"1","key":"pone.0350664.ref038","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1186\/s13063-016-1513-z","article-title":"A process evaluation of a cluster randomised trial to reduce potentially inappropriate prescribing in older people in primary care (OPTI-SCRIPT study)","volume":"17","author":"OPTI-SCRIPT study team","year":"2016","journal-title":"Trials"},{"issue":"6","key":"pone.0350664.ref039","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1370\/afm.1838","article-title":"Effectiveness of a Multifaceted Intervention for Potentially Inappropriate Prescribing in Older Patients in Primary Care: A Cluster-Randomized Controlled Trial (OPTI-SCRIPT Study)","volume":"13","author":"B Clyne","year":"2015","journal-title":"Ann Fam Med"},{"issue":"6","key":"pone.0350664.ref040","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1111\/hex.13630","article-title":"Patient and general practitioner experiences of implementing a medication review intervention in older people with multimorbidity: Process evaluation of the SPPiRE trial","volume":"25","author":"C McCarthy","year":"2022","journal-title":"Health Expect"},{"issue":"1","key":"pone.0350664.ref041","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003862","article-title":"GP-delivered medication review of polypharmacy, deprescribing, and patient priorities in older people with multimorbidity in Irish primary care (SPPiRE Study): A cluster randomised controlled trial","volume":"19","author":"C McCarthy","year":"2022","journal-title":"PLoS Med"},{"issue":"11","key":"pone.0350664.ref042","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-031438","article-title":"Can implementation failure or intervention failure explain the result of the 3D multimorbidity trial in general practice: mixed-methods process evaluation","volume":"9","author":"C Mann","year":"2019","journal-title":"BMJ Open"},{"issue":"1","key":"pone.0350664.ref043","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12877-021-02208-8","article-title":"A systematic review of the evidence for deprescribing interventions among older people living with frailty","volume":"21","author":"K Ibrahim","year":"2021","journal-title":"BMC Geriatr"},{"issue":"3","key":"pone.0350664.ref044","doi-asserted-by":"crossref","DOI":"10.3399\/bjgpopen20X101096","article-title":"Barriers and facilitators to deprescribing in primary care: a systematic review","volume":"4","author":"AJ Doherty","year":"2020","journal-title":"BJGP Open"},{"issue":"9","key":"pone.0350664.ref045","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/jgs.12418","article-title":"People\u2019s attitudes, beliefs, and experiences regarding polypharmacy and willingness to Deprescribe","volume":"61","author":"E Reeve","year":"2013","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"pone.0350664.ref046","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-017740","article-title":"Effectiveness of a complex intervention on Prioritising Multimedication in Multimorbidity (PRIMUM) in primary care: results of a pragmatic cluster randomised controlled trial","volume":"8","author":"C Muth","year":"2018","journal-title":"BMJ Open"},{"issue":"10141","key":"pone.0350664.ref047","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0140-6736(18)31308-4","article-title":"Management of multimorbidity using a patient-centred care model: a pragmatic cluster-randomised trial of the 3D approach","volume":"392","author":"C Salisbury","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"pone.0350664.ref048","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2125.2007.03071.x","article-title":"Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis","volume":"65","author":"R Holland","year":"2008","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"pone.0350664.ref049","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1186\/s12913-021-07062-3","article-title":"Process evaluation for the Care Homes Independent Pharmacist Prescriber Study (CHIPPS)","volume":"21","author":"L Birt","year":"2021","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"pone.0350664.ref050","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2125.2012.04178.x","article-title":"Medication review and reconciliation with cooperation between pharmacist and general practitioner and the benefit for the patient: a systematic review","volume":"74","author":"MME Geurts","year":"2012","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"pone.0350664.ref051","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ijpp.12039","article-title":"Description and process evaluation of pharmacists\u2019 interventions in a pharmacist-led information technology-enabled multicentre cluster randomised controlled trial for reducing medication errors in general practice (PINCER trial)","volume":"22","author":"PINCER trialists","year":"2014","journal-title":"Int J Pharm Pract"},{"key":"pone.0350664.ref052","article-title":"Optimizing Therapy to Prevent Avoidable Hospital Admissions in Multimorbid Older Adults (OPERAM): cluster randomised controlled trial","volume":"374","author":"MR Blum","year":"2021","journal-title":"BMJ"},{"issue":"12","key":"pone.0350664.ref053","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-049086","article-title":"Impact of the COVID-19 pandemic on ongoing health research: an ad hoc survey among investigators in Germany","volume":"11","author":"T Bratan","year":"2021","journal-title":"BMJ Open"},{"issue":"6","key":"pone.0350664.ref054","first-page":"495","article-title":"Health Services research in Germany in Times of COVID-19: How Does the Pandemic Influence Research Processes, Methods and the Personal Situation of Researchers? An Online Survey","volume":"85","author":"H Schnack","year":"2023","journal-title":"Gesundheitswesen"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0350664","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T17:27:02Z","timestamp":1783531622000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0350664"}},"subtitle":[],"editor":[{"given":"Vincenzo","family":"De Luca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":54,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0350664","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]}}}